Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
Annals of the Rheumatic Diseases|August 1, 2009
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA databaseT Sokka, H Kautiainen, T Pincus, et al.
Investigative Radiology|January 1, 1987
Observer variation in quantitative assessment of rheumatoid arthritis Part II. A simplified scoring systemJ J Kaye, E P Nance, L F Callahan, et al.
Investigative Radiology|December 1, 1986
Observer variation in quantitative assessment of rheumatoid arthritis. Part I. Scoring erosions and joint space narrowingE P Nance, J J Kaye, L F Callahan, et al.
The Journal of Rheumatology|December 1, 1992
Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: I. Nonsteroidal antiinflammatory drugsT Pincus, S B Marcum, L F Callahan, et al.
Pediatric Rheumatology Online Journal|April 14, 2023
The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality RegisterM Backström, H Salo, J Kärki, et al.
The Journal of Rheumatology|February 11, 1999
Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatologyF Wolfe, M Lassere, D van der Heijde, et al.
Arthritis and Rheumatism|September 30, 2008
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsD Aletaha, R Landewe, T Karonitsch, et al.
Annals of the Rheumatic Diseases|September 16, 2008
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendationsD Aletaha, R Landewe, T Karonitsch, et al.
Musculoskeletal Care|December 9, 2017
The feasibility and acceptability of a physical activity intervention for older people with chronic musculoskeletal pain: The iPOPP pilot trial protocolE L Healey, C Jinks, N E Foster, et al.
Scandinavian Journal of Rheumatology|April 4, 2017
Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohortT Rannio, J Asikainen, P Hannonen, et al.
Pageof 24